Can a stronger radiation dose ease bulky tumors better?
NCT ID NCT07291895
First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times
Summary
This study compares standard palliative radiotherapy (24 Gray in 3 sessions) with a higher dose (27 Gray in 3 sessions) for people with large metastatic tumors. The goal is to see if the higher dose improves tumor control without more side effects. About 20 adults with solid tumors and limited life expectancy will take part, and neither they nor their doctors will know which dose they receive.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BC Cancer - Vancouver
Vancouver, British Columbia, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill outsmart RAS-Mutant cancers?
- Could a personal coach at home boost energy for cancer patients?
- Personalized maintenance therapy: a smarter way to treat advanced cancer?
- Can a radioactive antibody light up hidden cancers on PET scans?
- Can a smart drug deliver a toxic payload directly to cancer cells?
- Fighting cancer wasting: can diet and exercise make olanzapine work better?